Home › Funds › Rosalind Advisors, Inc. › RGNT

Rosalind Advisors, Inc. position in RGNT

REGENTIS BIOMATERIALS LTD · Health Care

Rosalind Advisors, Inc. reported holding 701,685 shares of RGNT (REGENTIS BIOMATERIALS LTD) in its Q2 2026 13F filing — a position valued at US$2.5M, representing 0.92% of its reported portfolio and ranking #22 among its reported holdings. Rosalind Advisors, Inc. has disclosed RGNT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)701.68K sh
Reported value held$2.48M
Portfolio Weight0.92%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rosalind Advisors, Inc.'s RGNT position evolved

Rosalind Advisors, Inc. first disclosed a stake in RGNT in Q4 2025 at 251,510 shares (US$1.7M). The position peaked in Q2 2026 at 701,685 shares, worth US$2.5M. Across 3 filings, Rosalind Advisors, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 701,685 shares valued at US$2.5M — an increase of 450,175 shares quarter over quarter.. Notable position changes include a 179% increase in Q2 2026 (shares fell 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 251.51K $1.70M New
Q1 2026 251.51K $768.36K Hold
Q2 2026 701.68K $2.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGNT and 13F data

RGNT (REGENTIS BIOMATERIALS LTD) is a Health Care company. 5 other funds we track also report a position in RGNT. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGNT

No other tracked fund reports a position in RGNT.

All RGNT fund holders →

FAQ

How long has Rosalind Advisors, Inc. held RGNT?

Rosalind Advisors, Inc. has disclosed RGNT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Rosalind Advisors, Inc.'s current position in RGNT?

As of Q2 2026, Rosalind Advisors, Inc. holds 701.68K shares of RGNT (REGENTIS BIOMATERIALS LTD), valued at $2.48M, representing 0.92% of its reported portfolio and ranking #22.

Has Rosalind Advisors, Inc. been buying or selling RGNT?

In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. increased its position in RGNT. The position peaked in Q2 2026 at 701.68K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.